Plasma metabolite profile of legume consumption and future risk of type 2 diabetes and cardiovascular disease
© 2024. The Author(s)..
BACKGROUND: Legume consumption has been linked to a reduced risk of type 2 diabetes (T2D) and cardiovascular disease (CVD), while the potential association between plasma metabolites associated with legume consumption and the risk of cardiometabolic diseases has never been explored. Therefore, we aimed to identify a metabolite signature of legume consumption, and subsequently investigate its potential association with the incidence of T2D and CVD.
METHODS: The current cross-sectional and longitudinal analysis was conducted in 1833 PREDIMED study participants (mean age 67 years, 57.6% women) with available baseline metabolomic data. A subset of these participants with 1-year follow-up metabolomics data (n = 1522) was used for internal validation. Plasma metabolites were assessed through liquid chromatography-tandem mass spectrometry. Cross-sectional associations between 382 different known metabolites and legume consumption were performed using elastic net regression. Associations between the identified metabolite profile and incident T2D and CVD were estimated using multivariable Cox regression models.
RESULTS: Specific metabolic signatures of legume consumption were identified, these included amino acids, cortisol, and various classes of lipid metabolites including diacylglycerols, triacylglycerols, plasmalogens, sphingomyelins and other metabolites. Among these identified metabolites, 22 were negatively and 18 were positively associated with legume consumption. After adjustment for recognized risk factors and legume consumption, the identified legume metabolite profile was inversely associated with T2D incidence (hazard ratio (HR) per 1 SD: 0.75, 95% CI 0.61-0.94; p = 0.017), but not with CVD incidence risk (1.01, 95% CI 0.86-1.19; p = 0.817) over the follow-up period.
CONCLUSIONS: This study identified a set of 40 metabolites associated with legume consumption and with a reduced risk of T2D development in a Mediterranean population at high risk of cardiovascular disease.
TRIAL REGISTRATION: ISRCTN35739639.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
Cardiovascular diabetology - 23(2024), 1 vom: 20. Jan., Seite 38 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Margara-Escudero, Hernando J [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cardiovascular disease |
---|
Anmerkungen: |
Date Completed 22.01.2024 Date Revised 13.03.2024 published: Electronic ISRCTN: ISRCTN35739639 Citation Status MEDLINE |
---|
doi: |
10.1186/s12933-023-02111-z |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367362104 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367362104 | ||
003 | DE-627 | ||
005 | 20240314234925.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240121s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12933-023-02111-z |2 doi | |
028 | 5 | 2 | |a pubmed24n1329.xml |
035 | |a (DE-627)NLM367362104 | ||
035 | |a (NLM)38245716 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Margara-Escudero, Hernando J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Plasma metabolite profile of legume consumption and future risk of type 2 diabetes and cardiovascular disease |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.01.2024 | ||
500 | |a Date Revised 13.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a ISRCTN: ISRCTN35739639 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s). | ||
520 | |a BACKGROUND: Legume consumption has been linked to a reduced risk of type 2 diabetes (T2D) and cardiovascular disease (CVD), while the potential association between plasma metabolites associated with legume consumption and the risk of cardiometabolic diseases has never been explored. Therefore, we aimed to identify a metabolite signature of legume consumption, and subsequently investigate its potential association with the incidence of T2D and CVD | ||
520 | |a METHODS: The current cross-sectional and longitudinal analysis was conducted in 1833 PREDIMED study participants (mean age 67 years, 57.6% women) with available baseline metabolomic data. A subset of these participants with 1-year follow-up metabolomics data (n = 1522) was used for internal validation. Plasma metabolites were assessed through liquid chromatography-tandem mass spectrometry. Cross-sectional associations between 382 different known metabolites and legume consumption were performed using elastic net regression. Associations between the identified metabolite profile and incident T2D and CVD were estimated using multivariable Cox regression models | ||
520 | |a RESULTS: Specific metabolic signatures of legume consumption were identified, these included amino acids, cortisol, and various classes of lipid metabolites including diacylglycerols, triacylglycerols, plasmalogens, sphingomyelins and other metabolites. Among these identified metabolites, 22 were negatively and 18 were positively associated with legume consumption. After adjustment for recognized risk factors and legume consumption, the identified legume metabolite profile was inversely associated with T2D incidence (hazard ratio (HR) per 1 SD: 0.75, 95% CI 0.61-0.94; p = 0.017), but not with CVD incidence risk (1.01, 95% CI 0.86-1.19; p = 0.817) over the follow-up period | ||
520 | |a CONCLUSIONS: This study identified a set of 40 metabolites associated with legume consumption and with a reduced risk of T2D development in a Mediterranean population at high risk of cardiovascular disease | ||
520 | |a TRIAL REGISTRATION: ISRCTN35739639 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Cardiovascular disease | |
650 | 4 | |a Legumes | |
650 | 4 | |a Metabolomics | |
650 | 4 | |a Plasma | |
650 | 4 | |a Type 2 diabetes | |
700 | 1 | |a Paz-Graniel, Indira |e verfasserin |4 aut | |
700 | 1 | |a García-Gavilán, Jesús |e verfasserin |4 aut | |
700 | 1 | |a Ruiz-Canela, Miguel |e verfasserin |4 aut | |
700 | 1 | |a Sun, Qi |e verfasserin |4 aut | |
700 | 1 | |a Clish, Clary B |e verfasserin |4 aut | |
700 | 1 | |a Toledo, Estefania |e verfasserin |4 aut | |
700 | 1 | |a Corella, Dolores |e verfasserin |4 aut | |
700 | 1 | |a Estruch, Ramón |e verfasserin |4 aut | |
700 | 1 | |a Ros, Emilio |e verfasserin |4 aut | |
700 | 1 | |a Castañer, Olga |e verfasserin |4 aut | |
700 | 1 | |a Arós, Fernando |e verfasserin |4 aut | |
700 | 1 | |a Fiol, Miquel |e verfasserin |4 aut | |
700 | 1 | |a Guasch-Ferré, Marta |e verfasserin |4 aut | |
700 | 1 | |a Lapetra, José |e verfasserin |4 aut | |
700 | 1 | |a Razquin, Cristina |e verfasserin |4 aut | |
700 | 1 | |a Dennis, Courtney |e verfasserin |4 aut | |
700 | 1 | |a Deik, Amy |e verfasserin |4 aut | |
700 | 1 | |a Li, Jun |e verfasserin |4 aut | |
700 | 1 | |a Gómez-Gracia, Enrique |e verfasserin |4 aut | |
700 | 1 | |a Babio, Nancy |e verfasserin |4 aut | |
700 | 1 | |a Martínez-González, Miguel A |e verfasserin |4 aut | |
700 | 1 | |a Hu, Frank B |e verfasserin |4 aut | |
700 | 1 | |a Salas-Salvadó, Jordi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cardiovascular diabetology |d 2002 |g 23(2024), 1 vom: 20. Jan., Seite 38 |w (DE-627)NLM119878380 |x 1475-2840 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2024 |g number:1 |g day:20 |g month:01 |g pages:38 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12933-023-02111-z |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2024 |e 1 |b 20 |c 01 |h 38 |